Tagged with S

Puerto Rico Established 57 years ago, Bermudez, Longo, Díaz-Massó (BLDM) has played a key role in the rapid urbanization and industrialization of Puerto Rico, and today is the top specialty electrical and mechanical contractor in the Caribbean. Its president, Francisco Díaz Massó, explains how BLDM has fostered continued growth by diversifying its…

Sweden With almost three decades of experience in the Swedish life science industry, Jan Hellqvist, general manager of KLIFO in Sweden, explains why the country has seen the number of clinical studies from small and medium size companies skyrocket in recent years. Moreover, he discusses the possibilities of opening KLIFO’s affiliate…

Hungary Dr. Zsuzsanna Fürst, President of the Ethics Committee for Clinical Pharmacology, elaborates on the role and activities of the ethics committee, shares her insights on structural framework of the application process for clinical trials, and the future outlook of clinical research in Hungary.   Each and every application,  both initial…

Sweden TFS is a leading mid-size CRO providing clinical development solutions to biopharmaceutical companies. Headquartered in Lund, TFS serves global clinical trial markets with local expertise and worldwide project delivery. János Filakovský, MD, Ph.d. MBA, CEO of TFS, discusses the company’s unique capabilities and analyzes the Swedish life sciences industry’s potential…

Medtech Dr. Carlos Rivera Velez, president of the Puerto Rican Medical Device Cluster, shares the importance of the medtech industry for Puerto Rico and how the cluster is working with various stakeholders to position the island as a globally competitive industry hub.   We have seen Puerto Rico evolve into an…

Canada Marina Vasiliou took the reins as managing director of Biogen Canada in November 2017 after a long and varied career at MSD in a wide variety of geographies.   Canada’s biggest strengths are its diversity and openness—whether that is in health sciences or the culture itself Marina Vasiliou, Biogen Vasiliou…

Turkey There is perhaps no Turkish company in the healthcare sector that is more ambitious than Acıbadem. Not only has the private hospital group revolutionized healthcare in Turkey with its advanced facilities, but it has also pursued an ambitious internationalization campaign and even opened a world-class university, to boot.   We…

India The state of Gujarat proudly stands as India’s main pharmaceutical hub, accounting for over 33 percent of the country’s pharmaceutical turnover and 28 percent of its pharmaceutical exports.  Given the tremendous importance of the Indian industry globally, this state therefore emerges as a pharmaceutical hub of global importance.   For…

Turkey Dr Ferhat Farsi, CEO and founding partner of CinnaGen İlaç, shares his experience working for the largest biotech in the MENA region, Turkey’s important role within the global group, and his ambitious plans for the future.   “Having worked for leading Turkish companies for several years … I realized that…

Opinion This month, Aditya Bhattacharji takes stock of three political issues that are dominating Eurasia Group’s conversations with pharmaceutical firms: global protests, drug pricing, and India’s “Modicare” milestone.    Protests First, the rash of protests unfolding across parts of the Middle East, Asia, and Latin America has piqued firms’ attention—not just…

Sweden Niclas Källbom Karlsson, general manager of GSK Sweden, reflects on his first five years of heading the local affiliate, in which the company has emerged as a leader in the speciality respiratory medicines, vaccines and HIV area. With a new wave of products to be launched, he highlights the importance…

Singapore Vishal Doshi, founder and CEO of AUM Biosciences, shares his motivation behind establishing the company and his mission to build an ecosystem within AUM for a decentralized biotech innovation model; their focus on oncology and specifically small molecule cancer therapies; and the critical importance of the China market within their…